Influenza virus neuraminidase contributes to secondary bacterial pneumonia.
about
The role of respiratory viruses in the etiology of bacterial pneumonia: An ecological perspectivePolymicrobial community-acquired pneumonia: An emerging entityViral-bacterial interactions-therapeutic implicationsEpidemiology and management of common pulmonary diseases in older personsPostviral Complications: Bacterial PneumoniaInteraction between influenza virus and Streptococcus pneumoniae in severe pneumonia.Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection.Bacterial and viral infections associated with influenza.Insights into the interaction between influenza virus and pneumococcusExpression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumoniaInfluenza vaccines to control influenza-associated bacterial infection: where do we stand?Influenza-associated bacterial pneumonia; managing and controlling infection on two fronts.Deaths from bacterial pneumonia during 1918-19 influenza pandemic.Why is coinfection with influenza virus and bacteria so difficult to control?Quantitative detection of Staphylococcus aureus, Streptococcus pneumoniae and Haemophilus influenzae in patients with new influenza A (H1N1)/2009 and influenza A/2010 virus infectionA mouse model of lethal synergism between influenza virus and Haemophilus influenzae.Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza.Bench-to-bedside review: bacterial pneumonia with influenza - pathogenesis and clinical implications.Preventing and treating secondary bacterial infections with antiviral agentsOtolaryngological complications in patients infected with the influenza A (H1N1) virus.Passive immune neutralization strategies for prevention and control of influenza A infections.Recent advances in the diagnosis and treatment of influenza pneumonia.Kinetics of coinfection with influenza A virus and Streptococcus pneumoniae.Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology.Achievement of healthy people 2010 objective for adult pneumococcal vaccination in an American Indian community.Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniaeContribution of vaccine-induced immunity toward either the HA or the NA component of influenza viruses limits secondary bacterial complicationsThe personal touch: strategies toward personalized vaccines and predicting immune responses to them.Sialidase-based anti-influenza virus therapy protects against secondary pneumococcal infectionAmelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction.Influenza promotes pneumococcal growth during coinfection by providing host sialylated substrates as a nutrient source.Immunization with recombinant Streptococcus pneumoniae neuraminidase NanA protects chinchillas against nasopharyngeal colonization.A beneficiary role for neuraminidase in influenza virus penetration through the respiratory mucusCritical role of IL-1 receptor-associated kinase-M in regulating chemokine-dependent deleterious inflammation in murine influenza pneumonia.The airway epithelium: soldier in the fight against respiratory virusesRespiratory virus is a real pathogen in immunocompetent community-acquired pneumonia: comparing to influenza like illness and volunteer controlsViral and bacterial interactions in the upper respiratory tractInfluenza virus primes mice for pneumonia from Staphylococcus aureus.Influenza viral neuraminidase primes bacterial coinfection through TGF-β-mediated expression of host cell receptors.Immunotherapy with a combination of intravenous immune globulin and p4 peptide rescues mice from postinfluenza pneumococcal pneumonia.
P2860
Q26765407-7A331AC0-1368-4886-BEBC-34E5E6681950Q26780356-79CE9145-D72E-45AE-B53B-901C3F68554CQ26825261-EB5FE657-04C5-4B49-A234-AAC120945F06Q28397465-7583F7AF-5C7D-4743-BAB1-3FB790CDB442Q29248089-AF81BD9E-DA94-4AB4-98F3-A79FD3D35DC6Q30228581-A5DA4A4F-AECE-48B4-B14F-1E7A074060E3Q30353535-1ECB13A7-61AE-416E-B847-A121AC8D861AQ30353612-549E10EB-76CD-45E2-B54F-0A3FE0786B13Q30355570-43ABB5A0-E963-42BC-B3A4-31627C286B01Q30365855-38DA7321-ECBA-41B6-8B03-F27F8E5AFF7FQ30366650-B4D2CCDA-277D-43DB-BA80-54E4A32331DDQ30368552-E2548832-2D74-410E-85E7-06B92628351CQ30371219-BA44BA83-640C-425F-B152-CD90D880B70FQ30371269-E02DCE9A-606A-4FC0-9C94-6C22B9171843Q30374153-F0809E16-9206-43D6-8D51-9CDFFC360D48Q30383989-2753FE35-CDDF-44B9-8020-DAB4DDA1AC79Q30384053-195B8C70-63EA-40B9-8472-F6C78ECF7A96Q30389010-85F91227-9253-428F-9373-6CBE10136DEEQ30401260-78CE9A1C-9CC3-4EED-B2E3-73806B56E6EFQ30408146-7445F61E-0F56-438E-897B-6B91079F34E8Q30413158-0BF235C8-706A-4487-BDC2-FDE850B3B536Q30415002-52044243-A677-4B37-932C-3211A5363637Q30429002-1BD61A06-1BE3-4CF5-9B8B-1D3AFA01FF7DQ33591243-8D59BD7C-2CE0-4191-9064-A9397CCCD694Q33764411-C0A32A9F-F0E5-42E3-AF03-82BAFE2498E7Q33766431-E338117B-0C6B-46FB-989D-E2FD8355E5B5Q33769373-0BA07B19-8CEC-4396-A722-28317910BD68Q33813977-5F8BF28C-B4CD-44BA-B32F-E049BDA83055Q33867822-2712A71B-7933-4EAD-8420-08008B6D52F6Q33874812-96630A85-E71A-49D2-8EE5-F800AD6CC8ADQ33896536-37D79AE4-DA7E-4B07-AF35-8528C90567B8Q34111722-B731279A-767C-470F-B01B-A0503BDB4797Q34343986-A0F11BD2-2E25-4A46-90B6-3F291313A28BQ34369912-36C2C872-7811-47EC-A0C2-8C9E44EC0738Q34491598-870FBBAB-547A-4339-BD3A-CA8F512B45F7Q34539087-B3B160E5-10EF-4109-9F34-AF0AA23C3CA3Q34550727-08A454BF-C1B0-402E-B3C6-AF8494AD5B28Q34763964-1B612D87-73DB-42B8-81E2-9ACB33A83D58Q34925843-89044206-E741-4993-9D64-B7F6022FF529Q34933070-6E462CD5-401F-4A27-9086-F8A41868D3B6
P2860
Influenza virus neuraminidase contributes to secondary bacterial pneumonia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 June 2005
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Influenza virus neuraminidase contributes to secondary bacterial pneumonia.
@en
Influenza virus neuraminidase contributes to secondary bacterial pneumonia.
@nl
type
label
Influenza virus neuraminidase contributes to secondary bacterial pneumonia.
@en
Influenza virus neuraminidase contributes to secondary bacterial pneumonia.
@nl
prefLabel
Influenza virus neuraminidase contributes to secondary bacterial pneumonia.
@en
Influenza virus neuraminidase contributes to secondary bacterial pneumonia.
@nl
P2860
P356
P1476
Influenza virus neuraminidase contributes to secondary bacterial pneumonia.
@en
P2093
K Gopal Murti
Ville T Peltola
P2860
P304
P356
10.1086/430954
P407
P577
2005-06-08T00:00:00Z